Start Trading Now Get Started

DexCom (NASDAQ:DXCM) Stock Signal: Can Medicare CGM Coverage Expansion Spark a Rally?

By Adam Lemon
Chief Analyst and Director of Content

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked with...

Read more

Top Regulated Brokers

1
Get Started 74% of retail CFD accounts lose money Read Review

Long Trade Idea

Enter your long position between $59.65 (yesterday’s intra-day low) and $61.46 (yesterday’s intra-day high).

Market Index Analysis

  • DexCom (NASDAQ:DXCM) is a member of the NASDAQ 100 Index and the S&P 500 Index.

  • Both indices retreated from all-time highs amid rising inflation and decreasing wages but remain excessively high and disconnected from economic reality.

  • The Bull Bear Power Indicator for the S&P 500 Index is bullish with a negative divergence.

Market Sentiment Analysis

Equity futures are moderately recovering following yesterday’s mostly bearish sessions after April’s CPI report came in higher than expected at 3.8% annually, while real average hourly wages decreased 0.5% monthly and 0.3% annually. US President Trump will travel to China to meet President Xi, while Kevin Warsh received his Senate approval, and Cisco Systems and Alibaba Group earnings are likely to overshadow April’s PPI report.

DexCom Fundamental Analysis

DexCom is a leader in continuous glucose monitoring (CGM). Its G7 device is the most accurate CGM approved in the US, and DexCom is at the core of the MAHA (Make America Healthy Again) movement.

So, why am I bullish on DXCM at current levels?

DexCom beat revenue and earnings per share expectations of $1.17 billion and $0.47, reporting $1.19 billion and $0.56, respectively. I remain bullish on DXCM, driven by the pending Medicare CGM coverage expansion in type 2 diabetes patients not on insulin, which could add millions of new patients. I am equally bullish on its expansion into the wellness and metabolic health markets through the Stelo OTC sensor and strategic partnership with the Oura Ring.

Metric
Value
Verdict
P/E Ratio
26.24
Bullish
P/B Ratio
7.91
Bearish
PEG Ratio
1.13
Bullish
Current Ratio
1.95
Bullish
ROIC-WACC Ratio
Positive
Bullish

DexCom Fundamental Analysis Snapshot

The price-to-earning (P/E) ratio of 26.24 makes DXCM an inexpensive stock. By comparison, the P/E ratio for the S&P 500 Index is 31.86.

The average analyst price target for DXCM is $83.54. This suggests excellent upside potential with decreasing downside risks.

DexCom Technical Analysis

Today’s DXCM Signal

DXCM051326

DexCom Price Chart

  • The DXCM D1 chart shows price action breaking out above a horizontal support zone.

  • It also shows price action between its descending 0.0% and 38.2% Fibonacci Retracement Fan levels.

  • The Bull Bear Power Indicator is bearish with an ascending trendline, nearing a bullish crossover.

  • The average bullish trading volumes are higher than the average bearish trading volumes.

  • DXCM corrected as the S&P 500 Index recorded new all-time highs, a bearish signal, but bullish catalysts are rising.

My DXCM Long Stock Trade

  • DXCM Entry Level: Between $59.65 and $61.46

  • DXCM Take Profit: Between $83.54 and $86.05

  • DXCM Stop Loss: Between $48.50 and $51.05

  • Risk/Reward Ratio: 2.14

Ready to trade our analysis of DexCom? Here is our list of the best stockbrokers worth reviewing.

Chief Analyst and Director of Content

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked within financial markets over a 12-year period, including 6 years with Merrill Lynch.

As seen on: Pairs Of Aces, FX Street, FX Academy, TalkMarkets, Gold Eagle, Traders Union

Most Visited Forex Broker Reviews